Sorrento Therapeutics Inc (SRNE): Keeping my fingers crossed but their tra...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	2336
Boards Moderated	0
Alias Born	04/20/2006

1776club

Re: dia76ca post# 13099

Tuesday, 03/01/2022 1:38:30 AM

Tuesday, March 01, 2022 1:38:30 AM

Keeping my fingers crossed but their track record is not good.
Completed trials
ABIVERTINIB STI-5656 NCT04528667 P2 August 23, 2021 October 7, 2021 4 months
ABIVERTINIB STI-5656 NCT04440007 P2 July 1, 2021 August 23, 2021 6 months.
Those are in the USA but did I miss the Fast Track or P3?
Study Completion
ABIVERTINIB China NSCLC Phase 3 NCT03856697 is off the tracks for the USA until March 2024, But is China Pivotal and waiting for approval or delayed also? This is a major event and the stockholders have not been informed. Maybe a side remark from Dr. Ji that I missed.

I have not heard a squeak or a squark from SORRENTO on any of this and no P3 trial here in the USA.
I guess what I am saying is don't bet the farm on a reveal from home base.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM